These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases. Edwards CK Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I73-81. PubMed ID: 10577978 [TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4. Selmaj K; Walczak A; Mycko M; Berkowicz T; Kohno T; Raine CS Eur J Immunol; 1998 Jun; 28(6):2035-44. PubMed ID: 9645385 [TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement. Minden K; Aganna E; McDermott MF; Zink A Ann Rheum Dis; 2004 Oct; 63(10):1356-7. PubMed ID: 15361406 [No Abstract] [Full Text] [Related]
12. Tumour necrosis factor is trafficked to a mitochondrial tumour necrosis factor binding protein. Ledgerwood EC; Prins JB; Bright NA; Johnson DR; Wolfreys K; Pober JS; O'Rahilly S; Bradley JR Biochem Soc Trans; 1998 Nov; 26(4):S316. PubMed ID: 10047830 [No Abstract] [Full Text] [Related]
13. [1/2 The anti-TNF alpha drugs]. Medjoub M; Limat S; Woronoff-Lemsi MC Soins; 2007 Oct; (719):59-61. PubMed ID: 18020248 [No Abstract] [Full Text] [Related]
14. A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. Gimenez MA; Sim J; Archambault AS; Klein RS; Russell JH Am J Pathol; 2006 Apr; 168(4):1200-9. PubMed ID: 16565495 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis. Zhang X; Hupperts R; De Baets M Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225 [TBL] [Abstract][Full Text] [Related]
16. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Su X; Zhou T; Yang P; Edwards CK; Mountz JD Arthritis Rheum; 1998 Jan; 41(1):139-49. PubMed ID: 9433879 [TBL] [Abstract][Full Text] [Related]
17. The tumor-necrosis-factor-associated periodic syndrome, the brain, and tumor-necrosis-factor-alpha antagonists. Wildemann B; Rudofsky G; Kress B; Jarius S; Konig F; Schwenger V Neurology; 2007 May; 68(20):1742-4. PubMed ID: 17360963 [No Abstract] [Full Text] [Related]